Alliancebernstein L.P. Avrobio, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $22,725 - $40,299	-30,300 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $3,612 - $11,312	-2,800 Reduced 8.46%	30,300 $40,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $8,625 - $15,125	-2,500 Reduced 7.02%	33,100 $127,000
Q2 2021 Jul 30, 2021	BUY	$7.84 - $12.6 $56,448 - $90,720	7,200 Added 25.35%	35,600 $316,000
Q3 2020 Nov 12, 2020	SELL	$12.99 - $19.41 $20,784 - $31,056	-1,600 Reduced 5.33%	28,400 $370,000
Q2 2020 Aug 13, 2020	BUY	$12.19 - $22.96 $19,504 - $36,736	1,600 Added 5.63%	30,000 $524,000
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $180,736 - $300,032	12,800 Added 82.05%	28,400 $401,000
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $68,692 - $141,908	5,200 Added 50.0%	15,600 $254,000
Q1 2019 May 14, 2019	BUY	$12.46 - $22.05 $129,584 - $229,320	10,400 New	10,400 $229,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.